Advanced Enzyme Technologies Shares Surge 8% on Robust Q2 Performance

1 min read Updated on 12 Nov 2025, 11:04 AM

Reviewed by

Jubin VScanX News Team

AI Summary

Advanced Enzyme Technologies Ltd. stock rose 8% following impressive Q2 FY2024 results. Net profit increased 32% to ₹43.30 crore, revenue grew 26.4% to ₹184.50 crore, and EBITDA rose 42% to ₹60.00 crore year-over-year. EBITDA margin expanded by 350 basis points to 32.50%. The stock closed at ₹329.75 with a trading volume of 9.5 lakh shares, significantly higher than the 20-day average.

*this image is generated using AI for illustrative purposes only.

Advanced Enzyme Technologies Ltd. witnessed a significant uptick in its stock price, soaring 8% following the release of its September quarter results. The enzyme manufacturer demonstrated strong financial performance across key metrics, signaling robust growth and improved operational efficiency.

Financial Highlights

Metric	Q2 FY2024	Q2 FY2023	YoY Change
Net Profit	₹43.30 crore	₹33.00 crore	+32.00%
Revenue	₹184.50 crore	₹146.00 crore	+26.40%
EBITDA	₹60.00 crore	₹42.30 crore	+42.00%
EBITDA Margin	32.50%	29.00%	+350 bps

The company's financial results for the quarter ending September showcased impressive year-over-year growth. Net profit surged by 32.00% to ₹43.30 crore, up from ₹33.00 crore in the same quarter of the previous year. Revenue also saw a substantial increase of 26.40%, reaching ₹184.50 crore compared to ₹146.00 crore in the corresponding period last year.

Operational Efficiency

Advanced Enzyme Technologies demonstrated improved operational efficiency, with EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) growing by 42.00% to ₹60.00 crore from ₹42.30 crore year-over-year. The EBITDA margin expanded by 350 basis points, reaching 32.50% compared to 29.00% in the same quarter of the previous fiscal year.

Market Response

The stock market responded positively to the company's strong performance:

Closing price: ₹329.75
Trading volume: 9.5 lakh shares (significantly higher than the 20-day average of 53,000 shares)

While the stock has declined 6% year-to-date, it has gained a similar amount over the past month, indicating a potential shift in investor sentiment following the robust quarterly results.

Advanced Enzyme Technologies' strong quarterly performance, marked by significant growth in revenue and profitability, along with improved operational efficiency, has clearly resonated well with investors. The surge in trading volume suggests increased interest in the stock, potentially driven by the company's ability to deliver growth in a challenging economic environment.